Single-Use Technologies for Biopharmaceuticals: Global Markets

Published - May 2015| Analyst - Shalini Shahani Dewan| Code - BIO099B
Single-Use Technologies for Biopharmaceuticals: Global Markets
Single User License: $2,750 Member Price: FREE

Report Highlights

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

Report Includes

  • An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
  • Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
  • Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
  • Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
  • Relevant patent analysis.

Report Scope

The scope of this report includes the single-use technologies used in the bioprocessing industry. These are single-use bioreactors, membrane adsorbers, media bags, tubing and connectors, bioprocess containers, disposable mixing systems, samplers, filter cartridges, depth filtration system, tangential flow filtration system and other single-use products such as valves, clamps, etc.

The report covers market application areas such as monoclonal antibodies (mAbs), vaccines, gene therapy, recombinant proteins, blood derivatives and anti-cancer drugs, and the market by end users, which include contract manufacturing organizations and biopharmaceutical manufacturers. Excluded from this report are control software and the custom-designed software used with single-use biopharmaceutical manufacturing technologies.

BCC Research analyzes each market from a global scope and its application, regulatory environment, technologies involved, market projections and market shares. The emerging market covers countries like India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, Canada, etc.

Key restraints include leachables and extractables, cost constraints and breakage of bags. The report includes relevant patent analysis and comprehensive profiles of companies that lead the single-use technology market, such as EMD Millipore, GE Healthcare, Pall Corp., Sartorius Stedim Biotech and Thermo Fisher Scientific, among others.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Jan-2013| Analyst - Mahi Dutta| Code - BIO099A

Report Highlights

The global market for single-use technologies for biopharmaceuticals was valued at $720 million in 2011 and should reach $985.2 million in 2012.  Total market value is expected to reach nearly $2.4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.1%. 

Report Includes

  • An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges
  • Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs
  • Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares
  • Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns
  • Comprehensive company profiles of existing and potential market players
  • Patent analysis.
RELATED REPORTS
Share This Report